RUNX1 can be a master transcription variable that regulates the expression of various genes needed for hematopoiesis. Studies implied which the RUNX1 - "Our study uncovered the crucial position from the KLF16/MYC regulatory axis in modulating tumor development and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, such as https://walesq898cny0.idblogz.com/profile